A recent international multicenter clinical trial has demonstrated that VolumeRAD imaging of the chest offers improved detection and management of patients with lung nodules compared to conventional radiography.

Detection Improvement*
VolumeRAD significantly increases detection sensitivity, enabling the radiologist to confidently detect more lung nodules than 2-view chest X-ray (CXR).

Patient Management*
Radiologists are significantly more accurate at correctly dentifying cases requiring follow-up with VolumeRAD than with 2-view chest X-ray.

Dose Reduction*
With a VolumeRAD Tomosynthesis exam, including a standard PA image, patients receive only 1.6 times more radiation than they do with a two-view (PA and LAT) chest X-ay exam.